| Recruiting | PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability i Ischemic Cardiomyopathy, Heart Failure | Phase 2 | 2025-12-18 |
| Recruiting | Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angi Coronary Artery Disease(CAD) | Phase 3 | 2025-11-14 |
| Recruiting | A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmaco Prostate Cancer | Phase 1 | 2025-06-07 |
| Recruiting | Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Pros Prostate Cancer | N/A | 2025-03-14 |
| Terminated | Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis Myocardial Perfusion Imaging, Diagnostic Certainty, Stable Coronary Artery Disease | Phase 2 | 2024-12-19 |
| Recruiting | Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD Alzheimer Disease, Neurofibrillary Tangle | Phase 3 | 2024-11-20 |
| Active Not Recruiting | A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms Advanced Neuroendocrine Neoplasm | Phase 2 / Phase 3 | 2024-06-11 |
| Recruiting | Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer Prostate Cancer | Phase 1 / Phase 2 | 2023-09-13 |
| Completed | A Study to Evaluate XTR006 in Chinese Volunteers Alzheimer Disease | Phase 1 | 2023-06-12 |
| Completed | Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Sub Alzheimer Disease | N/A | 2022-09-01 |
| Active Not Recruiting | A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GE Neuroendocrine Tumors | Phase 3 | 2022-08-31 |
| Completed | Evaluation of XTR004 as a Novel 18F-labeled PET MPI Tracer in Diagnosis of Known or Suspected CAD Coronary Artery Disease (CAD) | Phase 2 | 2022-02-15 |
| Completed | XTR003 PET Radiotracer for the Detection of Viable Myocardium Ischemic Heart Disease (IHD) | Phase 2 | 2021-12-15 |
| Unknown | Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors Solid Tumor | EARLY_Phase 1 | 2021-05-01 |
| Completed | A Phase I Study to Evaluate XTR003 in Healthy Chinese Volunteers Coronary Artery Disease (CAD) | Phase 1 | 2021-03-29 |
| Completed | A Study of XTR004 Radiotracer in Healthy Volunteers Coronary Artery Disease (CAD), Myocardial Ischemia | Phase 1 | 2021-03-23 |
| Completed | A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Alzheimer Disease, Dementia, Brain Diseases | N/A | 2021-01-28 |